Patents by Inventor Sylvie Marin

Sylvie Marin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIII factors for the treatment of type A hemophilia
    Patent number: 8623824
    Abstract: The present invention relates to improved human FVIII variants having at least one substitution in the A2 and/or C2 domain. The present invention also relates to their uses in the treatment of hemophilia A, particularly in patients with inhibitors.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: January 7, 2014
    Assignees: Biomethodes, Hospices Civils de Lyon
    Inventors: Didier Saboulard, Jean-Luc Plantier, Marc Delcourt, Claude Negrier, Thierry Menguy, Stephane Blesa, Sylvie Marin
  • Novel VIII Factors for the Treatment of Type A Hemophilia
    Publication number: 20100311659
    Abstract: The present invention relates to improved human FVIII variants having at least one substitution in the A2 and/or C2 domain. The present invention also relates to their uses in the treatment of hemophilia A, particularly in patients with inhibitors.
    Type: Application
    Filed: February 22, 2008
    Publication date: December 9, 2010
    Applicants: BIOMETHODES, HOSPICES CIVILS DE LYON
    Inventors: Didier Saboulard, Jean-Luc Plantier, Marc Delcourt, Claude Negrier, Thierry Menguy, Stephane Blesa, Sylvie Marin